In addition, the combination of elevated plasma glucose levels (hyperglycemia) and high insulin concentrations (hyperinsulinemia) promote hepatic de novo FA lipogenesis and impair β-oxidation, thereby contributing to the development of hepatic steatosis [94]. The gene discussed is INS; the disease is Hyperglycemia.